Bacterial Endocarditis — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for bacterial endocarditis. 14 active patents protecting 2 drugs from 2+ originators. First major cliff: 2035. Daily refresh.

2
Approved drugs
14
Active US patents
49/100
Avg vulnerability
—
Annual revenue covered

Originators in Bacterial Endocarditis

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Baxter 9 patents ANI Pharmaceuticals 5 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating bacterial endocarditis. Each bar = one year. Y-axis scaled to peak year (5 patents).

3
28
4
32
5
35
2
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Metro I.V. In Plastic Container
METRONIDAZOLE
 Baxter 9 58 — 2028-02-02
Vancocin
vancomycin
 ANI Pharmaceuticals 5 39 — 2035-11-06

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8658678 Metro I.V. In Plastic Container method of use 75 2028-06-27
12257236 Metro I.V. In Plastic Container method of use 75 2039-01-16
9198858 Metro I.V. In Plastic Container method of use 62 2032-06-28
8946276 Metro I.V. In Plastic Container method of use 62 2032-06-28
8877792 Metro I.V. In Plastic Container formulation 55 2028-02-02
7893097 Metro I.V. In Plastic Container formulation 55 2028-02-19
11517609 Vancocin method of use 53 2035-11-06
11541035 Metro I.V. In Plastic Container formulation 50 2039-10-04
10039804 Vancocin method of use 45 2035-11-06
10188697 Vancocin method of use 45 2035-11-06

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10849956 Vancocin formulation 25 2035-11-06
11000567 Vancocin formulation 25 2035-11-06
10238634 Metro I.V. In Plastic Container formulation 42 2032-06-28
10596155 Metro I.V. In Plastic Container formulation 42 2032-06-28
10188697 Vancocin method of use 45 2035-11-06
10039804 Vancocin method of use 45 2035-11-06
11541035 Metro I.V. In Plastic Container formulation 50 2039-10-04
11517609 Vancocin method of use 53 2035-11-06
7893097 Metro I.V. In Plastic Container formulation 55 2028-02-19
8877792 Metro I.V. In Plastic Container formulation 55 2028-02-02

Related